You are here:

budesonide gastro-resistant granules (Budenofalk®)

Advice

following an abbreviated submission:

budesonide gastro-resistant granules (Budenofalk®) is accepted for use within NHS Scotland.

Indication under review: induction of remission in patients with mild to moderate active Crohn’s disease affecting the ileum and/or ascending colon.

Budesonide gastro-resistant granules provide a once daily alternative to budesonide gastro-resistant 3mg capsules three times daily at no additional cost. The granules may have advantages for patients who have difficulty swallowing.
 

Drug Details

Drug Name: budesonide gastro-resistant granules (Budenofalk®)
SMC Drug ID: 970/14
Manufacturer: Dr Falk Pharma UK
Indication: Induction of remission in patients with mild to moderate active Crohn’s disease affecting the ileum and/or ascending colon.
BNF Category:
Sub Category: 1.5 Chronic bowel disorders
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 June 2014

Back